(Q50768068)

18 March 2018

title

CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease. (English)

1 reference

18 March 2018

1 reference

M N Dworzak

1

1 reference

18 March 2018

G Fröschl

2

1 reference

18 March 2018

D Printz

3

1 reference

18 March 2018

L De Zen

4

1 reference

18 March 2018

G Gaipa

5

1 reference

18 March 2018

R Ratei

6

1 reference

18 March 2018

G Basso

7

1 reference

18 March 2018

A Biondi

8

1 reference

18 March 2018

W-D Ludwig

9

1 reference

18 March 2018

H Gadner

10

1 reference

18 March 2018

publication date

1 April 2004

1 reference

18 March 2018

published in

Leukemia

1 reference

18 March 2018

volume

18

1 reference

18 March 2018

issue

4

1 reference

18 March 2018

page(s)

703-708

1 reference

18 March 2018

Molecular genetics of MIC2: a gene shared by the human X and Y chromosomes

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberrati

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

CD99 (MIC2) expression in paediatric B-lineage leukaemia/lymphoma reflects maturation-associated patterns of normal B-lymphopoiesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: a study of five cases controlled by genetic methods.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Detection of leukaemic lymphoblasts in CSF by immunofluorescence for terminal transferase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403303

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403303

1 reference

18 March 2018

Dimensions Publication ID

1040201390

0 references

1 reference

18 March 2018